4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-25-082668
Chief Technical Officer sold 4,188 shares at $100.07 ($419,091)
- Chief Technical Officer acquired 4,188 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shulman Joseph Chief Technical Officer | 2025-08-21 | Option exercise 10b5-1 | +4,188 | $27.35 | $114,542 | 12,697 | D |
| Shulman Joseph Chief Technical Officer | 2025-08-21 | Sale 10b5-1 | −4,188 | $100.07 | $419,091 | 8,509 | D |
| Derivatives | |||||||
| Shulman Joseph Chief Technical Officer | 2025-08-21 | Option exercise · Stock Options (Right to Buy) 10b5-1 | −4,188 | 18,844 | D | ||
| Open-market sales · 4,188 sh · avg $100.07 · $419,091 | |||||||
Loading xslF345X05/tm2524281-1_4seq1.xml…